"The high-quality research environment at Genentech and collaborative work opportunities of experimental and bioinformatics scientists is truly unrivalled in our field."
I joined Genentech in early 2011 as the company was expanding its use of NGS sequencing in research. For many years, I was part of the NGS sequencing core lab bringing in and exploring the latest sequencing technologies.
Earlier in my career, I worked at Illumina which gave me a very early insight into the potential revolution that sequencing would bring to all aspects of biology research. Joining Genentech enabled me to apply these latest sequencing technologies in cancer research resulting in several high-profile publications of genomic characterizations of cancer types. A highlight for me from these studies was our finding of recurrent RSPO fusions in colorectal cancer which we published in Nature. As a bioinformatics scientist to find these genomic aberrations in silico and then have them validate in the lab and published is a truly thrilling experience.
Guiding the next-generation of bioinformatics scientists is a true passion of mine. At Genentech we get to mentor our postdoctoral scientists with ground breaking academic basic research projects and at the same time enable them to explore the industry aspects of our scientific endeavors.
Nature. 2012 Aug 30;488(7413):660-4. doi: 10.1038/nature11282.PMID: 22895193
My current research focusses largely in three areas: